Advertisement
Screener

ZAI LAB LIMITED (ZLAB) Operating Lease, Payments

2.8 / 5 stars · 68/120 Roast Me

ZAI LAB LIMITED Operating Lease, Payments

ZAI LAB LIMITED (ZLAB) reported Operating Lease, Payments of $8.69 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:OperatingLeasePayments · last filed 2026-02-26

  • ZAI LAB LIMITED operating lease, payments for fiscal 2025 was $8.69M, a 1.57% decline from fiscal 2024.
  • ZAI LAB LIMITED operating lease, payments for fiscal 2024 was $8.83M, a 5.22% decline from fiscal 2023.
  • ZAI LAB LIMITED operating lease, payments for fiscal 2023 was $9.32M, a 15.25% increase from fiscal 2022.
  • ZAI LAB LIMITED operating lease, payments for fiscal 2022 was $8.08M, a 38.42% increase from fiscal 2021.
Period endOperating Lease, Payments 6 monthOperating Lease, Payments 12 month
2025-12-31$8.69M
10-K · filed 2026-02-26
2024-12-31$8.83M
10-K · filed 2026-02-26
2023-12-31$9.32M
10-K · filed 2026-02-26
2022-12-31$8.08M
10-K · filed 2025-02-27
2021-12-31$5.84M
10-K · filed 2024-02-27
2020-12-31$4.06M
10-K · filed 2023-03-01
2020-06-30$1.99M
6-K · filed 2020-09-11
2019-12-31$2.78M
10-K · filed 2022-03-01
2019-06-30$1.06M
6-K · filed 2020-09-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67